Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Beneficial Ownership Report · SCHEDULE 13G

Geron Corporation

GERNNASDAQEQUITYCurrent

Beneficial Ownership Report

Filed Nov 10, 2026Accepted Nov 10, 2026, 7:31 AM ESTFiling CIK 886744Accession 0000093751-26-000662
Share

Structured filing — SCHEDULE 13G

primary_doc.xml

Open full document ↗

Subject company

Company
GERON CORP
Company CIK
0000886744
Street
149 COMMONWEALTH DRIVE SUITE 2070
City
MENLO PARK
State / country code
CA
Postal code
94025

Statement details

Security class
COMMON STOCK
Event date
09/30/2026
Rule designation
Rule 13d-1(b)

Reporting person 1

Name
STATE STREET CORPORATION
Citizenship / organization
MA
Reporting person type
HC
Aggregate amount owned
31,896,515.00
Percent of class
5
Sole voting power
0.00
Shared voting power
30,180,644.00
Sole dispositive power
0.00
Shared dispositive power
31,896,515.00
Aggregate excludes certain shares
N

Item 1

Issuer

GERON CORP

Principal executive office address

149 COMMONWEALTH DRIVE SUITE 2070, MENLO PARK, CALIFORNIA, 94025

Item 2

Citizenship

MA

Filing person

STATE STREET CORPORATION;

Principal business or residence address

ONE CONGRESS STREET, SUITE 1, BOSTON MA 02114, UNITED STATES

Item 3

Not applicable indication

N

Type of filing person

IA · HC

Item 4

Percent of class

5

Amount beneficially owned

31896515.00

Sole voting power

0

Shared voting power

30,180,644

Sole dispositive power

0

Shared dispositive power

31,896,515

Item 5

Not applicable indication

N

Ownership of 5% or less

Y

Item 6

Not applicable indication

N

Ownership on behalf of another person

NOT APPLICABLE

Item 7

Not applicable indication

N

Subsidiaries

SSGA FUNDS MANAGEMENT, INC. (IA);STATE STREET GLOBAL ADVISORS EUROPE LIMITED (IA);STATE STREET GLOBAL ADVISORS LIMITED (IA);STATE STREET GLOBAL ADVISORS TRUST COMPANY (IA);STATE STREET GLOBAL ADVISORS, LTD. (IA);

Item 8

Not applicable indication

N

Group members

NOT APPLICABLE

Item 9

Not applicable indication

N

Item 10

Not applicable indication

N

Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Signature 1

Reporting person
STATE STREET CORPORATION
Signed
ALOK MAHESHWARY
Title
SENIOR VICE PRESIDENT
Date
11/09/2026

Company context

meaningful moments for people living with blood cancer. Because patients cannot wait, we approach our work with urgency, bringing together deep expertise in telomerase biology with patient perspectives and insights from clinical research and real-world care. Our medicine, RYTELO® (imetelstat), is approved in the United States and European Union for certain patients with lower-risk myelodysplastic syndromes (LR-MDS). Geron is a commercial-stage company with offices in Parsippany, New Jersey and Foster City, California. To learn more, visit www.geron.com or follow us on LinkedIn.

Current securities

Historical securities (1)

Recent company filings

  1. 4 filingNov 16, 2026
  2. 4 filingNov 16, 2026
  3. 10-Q filingNov 4, 2026
  4. Results of Operations and Financial ConditionNov 4, 2026
  5. Other EventsOct 28, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.